593.87 USD
+11.53 (+1.98%)
593.87 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 83% to MDGL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 611.04. This target is 2.89% above the current price.
MDGL was analyzed by 23 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about MDGL.
In the previous month the buy percentage consensus was at a similar level.
MDGL was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-19 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-12-11 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-11-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-20 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-11-19 | Truist Securities | Maintains | Buy -> Buy |
| 2025-11-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-11-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-05 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-11-05 | Cantor Fitzgerald | Upgrade | Neutral -> Overweight |
| 2025-11-03 | B of A Securities | Upgrade | Underperform -> Neutral |
| 2025-10-15 | Truist Securities | Initiate | Buy |
| 2025-10-15 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-10 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-09-29 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-09-12 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-26 | TD Cowen | Maintains | Buy -> Buy |
| 2025-08-20 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-08-12 | UBS | Maintains | Buy -> Buy |
| 2025-08-06 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-05-02 | UBS | Maintains | Buy -> Buy |
| 2025-05-02 | B. Riley Securities | Reiterate | Buy -> Buy |
| 2025-05-02 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-04-24 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-27 | Citigroup | Maintains | Buy -> Buy |
| 2025-02-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-10 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-11-20 | Cantor Fitzgerald | Reiterate | Neutral |
| 2024-11-05 | B. Riley Securities | Maintains | Neutral -> Neutral |
| 2024-11-01 | UBS | Maintains | Buy -> Buy |
MADRIGAL PHARMACEUTICALS INC / MDGL FAQ
What is the average price target for MADRIGAL PHARMACEUTICALS INC (MDGL) stock?
23 analysts have analysed MDGL and the average price target is 611.04 USD. This implies a price increase of 2.89% is expected in the next year compared to the current price of 593.87.
Can you provide the consensus rating for MADRIGAL PHARMACEUTICALS INC stock?
The consensus rating for MADRIGAL PHARMACEUTICALS INC (MDGL) is 83.4783 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for MDGL stock?
The number of analysts covering MADRIGAL PHARMACEUTICALS INC (MDGL) is 23.